Verona Pharma plc (VRNA) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts VRNA Hot Sheet
Join SI Premium – FREE
Verona Pharma plc (NASDAQ: VRNA) reported Q2 EPS of ($0.11), $0.06 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Electra Therapeutics files for proposed IPO
- AiRWA receives Nasdaq deficiency notice over late 10-K filing
- Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
